A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of BA058 Administered Via a Coated Transdermal Microarray Delivery System (BA058 Transdermal) in Healthy Postmenopausal Women With Osteoporosis
Phase of Trial: Phase II
Latest Information Update: 21 Dec 2016
At a glance
- Drugs Abaloparatide (Primary) ; Abaloparatide (Primary)
- Indications Postmenopausal osteoporosis
- Focus Proof of concept; Therapeutic Use
- Sponsors Radius Health Inc.
- 19 Sep 2016 Results published in the Radius Health Inc Media Release
- 19 Sep 2016 Results from this trial presented at the American Society for Bone and Mineral Research (ASBMR) 2016 Annual Meeting, according to a Radius Health Inc media release.
- 03 Mar 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History